You are here: Industry Insights > COVID-19

News List

Pankajakasthuri declares final clinical trials of ZingiVir-H as adjunct therapy for COVID-19 patients expresspharma
August 07, 2020
Patients reported negative RT PCR recovery in an average of five days, all results submitted to AYUSH for necessary approval.
ImmunityBio’s hAd5 vaccine candidate for Covid-19 succeeds in preclinical study pharmaceutical-business-review
August 06, 2020
ImmunityBio said that its human Ad5 vaccine candidate (hAd5 vaccine candidate), which is being developed for the prevention of Covid-19, has yielded positive preclinical results.
FDA approves IND for PSC’s stem cell therapy candidate for Covid-19 pharmaceutical-business-review
August 06, 2020
Calidi Biotherapeutics said that the Investigational New Drug (IND) application submitted by its partner, Personalized Stem Cells, Inc. (PSC), has received FDA approval for the treatment of COVID-19 and pneumonia patients using stem cell therapy.
Direct Biologics Receives FDA Approval to Initiate “EXIT-COVID-19” Drug Trial americanpharmaceuticalreview
August 06, 2020
Direct Biologics has received approval from FDA that it may proceed with a Phase II trial under an Investigational New Drug (IND) application for the use of ExoFlo?, a bone marrow-derived extracellular vesicle and exosome product, in the treatment of ...
Seqirus Begins Shipping 2020/21 Influenza Vaccines to U.S. Market americanpharmaceuticalreview
August 06, 2020
Seqirus has begun shipping its portfolio of seasonal influenza vaccines to customers in the U.S. for the 2020/21 influenza season.
Constant Therapeutics Announces Start of Phase 2 Trial of Peptide Drug TXA127 for COVID-19 americanpharmaceuticalreview
August 06, 2020
Constant Therapeutics announced its peptide drug TXA127, a pharmaceutical formulation of the natural human peptide angiotensin-(1-7), will be tested in a Phase 2 clinical trial at Columbia University Irving Medical Center in New York, New York.
COVID-19 DNA Vaccine Targeting SARS-CoV-2 Proven Effective in Non-Human Primates americanpharmaceuticalreview
August 06, 2020
INOVIO announced its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting non-human primates (NHPs; specifically rhesus macaques) from live virus challenge 13 weeks after the last vaccination.
Interleukin-6 inhibitors improve outcomes for COVID-19 patients in study europeanpharmaceuticalreview
August 06, 2020
Researchers have shown that symptoms in patients experiencing severe COVID-19 improved when given either sarilumab or tocilizumab, interleukin-6 inhibitors.
COVID-19 poll: Disrupted clinical trials will take six to 12 months to return to normal pharmaceutical-technology
August 06, 2020
The COVID-19 pandemic significantly disrupted ongoing clinical trials in various stages, with more than 1,000 trials by sponsors, collaborators, or contract research organisations having gone off the trial schedules.
Improved patient access seen as the main benefit of telemedicine: Poll pharmaceutical-technology
August 06, 2020
Regulatory and privacy concerns have hindered the adoption of telemedicine despite the service existing for a while. The COVID-19 pandemic, however, resulted in significant uptake of telemedicine services.